EUVIMEDEUVIMED entdecken
Crossref

Effect of eribulin on epithelial–mesenchymal transition plasticity in metastatic breast cancer: An exploratory, prospective study

Takanori Hayashi iD, Naomi Kobayashi, Kaori Ushida, Naoya Asai, Shogo Nakano, Kimihito Fujii, Takahito Ando, Toshiaki Utsumi iD

Genes to Cells · 2023-05 · 28 (5) · 364-373

DOI: 10.1111/gtc.13019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes to Cells, online erschienen am 12.03.2023. Verfasst von Takanori Hayashi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Fujita Health University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial–mesenchymal transition (EMT) plays a pivotal role in cancer metastasis and treatment resistance, which worsens prognosis. In phase III trials, eribulin improved overall survival in metastatic breast cancer (MBC) patients. In preclinical studies, eribulin suppressed EMT. However, clinical data on the use of eribulin for MBC patients are limited. In this exploratory, prospective study, we examined the effect of eribulin on EMT in MBC patients. Twenty‐two patients aged 44–82 years with recurrent breast cancer or MBC were treated with eribulin. Breast cancer tissue samples were obtained before treatment and on Day 15 ± 5 of the first cycle of eribulin treatment. EMT markers (E‐cadherin, claudin‐3, vimentin, and N‐cadherin) were analyzed using western blotting. EMT changes were evaluated based on the ratio of epithelial to mesenchymal markers before and after treatment in individual tumors. E‐cadherin/vimentin, claudin‐3/vimentin, E‐cadherin/N‐cadherin, and claudin‐3/N‐cadherin ratios were significantly higher after treatment ( p = .007, p = .005, p = .006, and p = .011, respectively). Based on E‐cadherin/vimentin, 65.0% of tumors shifted to an epithelial phenotype, as compared to 66.7% based on claudin‐3/vimentin, 84.6% based on E‐cadherin/N‐cadherin, and 71.4% based on claudin‐3/N‐cadherin ratios. Thus, our results showed that eribulin suppressed EMT in breast cancer tissues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionNeoplasmsHumansVimentinProspective StudiesClaudin-3CadherinsFuransKetonesPolyether Polyketides

Stichwörter der Autor:innen

breast cancerdrug-resistantepithelial-mesenchymal transitioneribulinprospective study

Substanzen

VimentinClaudin-3CadherinseribulinFuransKetonesPolyether Polyketides

Autor:innen und Institutionen

  • Department of Biochemistry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Department of Breast Surgery, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Aichi, Japan.
  • Department of Pathology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Division of Breast and Endocrine Surgery, Department of Surgery, Aichi Medical University, Nagakute, Aichi, Japan.
  • Department of Surgery, Fujita Health University School of Medicine, Nagoya, Aichi, Japan.

ORCID-Profile: Takanori Hayashi, Toshiaki Utsumi

Förderung

  • Fujita Health University

Zitieren

APA

Hayashi, T., Kobayashi, N., Ushida, K., Asai, N., Nakano, S., Fujii, K., Ando, T., & Utsumi, T. (2023). Effect of eribulin on epithelial–mesenchymal transition plasticity in metastatic breast cancer: An exploratory, prospective study. Genes to Cells, 28(5), 364-373. https://doi.org/10.1111/gtc.13019

Vancouver

Hayashi T, Kobayashi N, Ushida K, Asai N, Nakano S, Fujii K, et al. Effect of eribulin on epithelial–mesenchymal transition plasticity in metastatic breast cancer: An exploratory, prospective study. Genes to Cells. 2023;28(5):364-373. doi:10.1111/gtc.13019

BibTeX
@article{Hayashi2023,
  author = {Hayashi, Takanori and Kobayashi, Naomi and Ushida, Kaori and Asai, Naoya and Nakano, Shogo and Fujii, Kimihito and Ando, Takahito and Utsumi, Toshiaki},
  title = {Effect of eribulin on epithelial–mesenchymal transition plasticity in metastatic breast cancer: An exploratory, prospective study},
  journal = {Genes to Cells},
  year = {2023},
  volume = {28},
  number = {5},
  pages = {364--373},
  doi = {10.1111/gtc.13019}
}
Kostenlos starten →